Andrew Burch - 30 Apr 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
President, Nucleic Acid Production
Signature
/s/ Kurt Oreshack, by power of attorney for Andrew Burch
Issuer symbol
MRVI
Transactions as of
30 Apr 2024
Net transactions value
+$9,798
Form type
4
Filing time
02 May 2024, 18:46:24 UTC
Previous filing
16 Apr 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $9,798 +1,719 +0.41% $5.70 421,754 30 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,719 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

President, Nucleic Acid Production